Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy

Detalles Bibliográficos
Autores principales: Phani, Nagaraja, Rai, Padmalatha, Adhikari, Prabha, Nagri, Shivashankara, D’Souza, Sydney, Gopinath, Mundyat, Satyamoorthy, Kapaettu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044261/
http://dx.doi.org/10.1186/1755-8166-7-S1-P100
_version_ 1782319113180282880
author Phani, Nagaraja
Rai, Padmalatha
Adhikari, Prabha
Nagri, Shivashankara
D’Souza, Sydney
Gopinath, Mundyat
Satyamoorthy, Kapaettu
author_facet Phani, Nagaraja
Rai, Padmalatha
Adhikari, Prabha
Nagri, Shivashankara
D’Souza, Sydney
Gopinath, Mundyat
Satyamoorthy, Kapaettu
author_sort Phani, Nagaraja
collection PubMed
description
format Online
Article
Text
id pubmed-4044261
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40442612014-06-19 Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy Phani, Nagaraja Rai, Padmalatha Adhikari, Prabha Nagri, Shivashankara D’Souza, Sydney Gopinath, Mundyat Satyamoorthy, Kapaettu Mol Cytogenet Poster Presentation BioMed Central 2014-01-21 /pmc/articles/PMC4044261/ http://dx.doi.org/10.1186/1755-8166-7-S1-P100 Text en Copyright © 2014 Phani et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Phani, Nagaraja
Rai, Padmalatha
Adhikari, Prabha
Nagri, Shivashankara
D’Souza, Sydney
Gopinath, Mundyat
Satyamoorthy, Kapaettu
Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy
title Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy
title_full Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy
title_fullStr Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy
title_full_unstemmed Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy
title_short Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy
title_sort impact of kcnj11, tcf7l2, slc30a8, igf2bp2, pparg, slc47a1, stk11, hhex, kcnq1, cdkal1, fto, cyp2c9, adipoq, capn10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044261/
http://dx.doi.org/10.1186/1755-8166-7-S1-P100
work_keys_str_mv AT phaninagaraja impactofkcnj11tcf7l2slc30a8igf2bp2ppargslc47a1stk11hhexkcnq1cdkal1ftocyp2c9adipoqcapn10genepolymorphismsonriskoftype2diabetesandtherapeuticresponsetosulfonylureaandmetformintherapy
AT raipadmalatha impactofkcnj11tcf7l2slc30a8igf2bp2ppargslc47a1stk11hhexkcnq1cdkal1ftocyp2c9adipoqcapn10genepolymorphismsonriskoftype2diabetesandtherapeuticresponsetosulfonylureaandmetformintherapy
AT adhikariprabha impactofkcnj11tcf7l2slc30a8igf2bp2ppargslc47a1stk11hhexkcnq1cdkal1ftocyp2c9adipoqcapn10genepolymorphismsonriskoftype2diabetesandtherapeuticresponsetosulfonylureaandmetformintherapy
AT nagrishivashankara impactofkcnj11tcf7l2slc30a8igf2bp2ppargslc47a1stk11hhexkcnq1cdkal1ftocyp2c9adipoqcapn10genepolymorphismsonriskoftype2diabetesandtherapeuticresponsetosulfonylureaandmetformintherapy
AT dsouzasydney impactofkcnj11tcf7l2slc30a8igf2bp2ppargslc47a1stk11hhexkcnq1cdkal1ftocyp2c9adipoqcapn10genepolymorphismsonriskoftype2diabetesandtherapeuticresponsetosulfonylureaandmetformintherapy
AT gopinathmundyat impactofkcnj11tcf7l2slc30a8igf2bp2ppargslc47a1stk11hhexkcnq1cdkal1ftocyp2c9adipoqcapn10genepolymorphismsonriskoftype2diabetesandtherapeuticresponsetosulfonylureaandmetformintherapy
AT satyamoorthykapaettu impactofkcnj11tcf7l2slc30a8igf2bp2ppargslc47a1stk11hhexkcnq1cdkal1ftocyp2c9adipoqcapn10genepolymorphismsonriskoftype2diabetesandtherapeuticresponsetosulfonylureaandmetformintherapy

Ejemplares similares